Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients-Reference-Cited by-同舟云学术

Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients

Published:2007-04-15 Issue:8 Volume:109 Page:1532-1535
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Trifilio Steve,Pennick Gennethel,Pi Judy,Zook Jennifer,Golf Mary,Kaniecki Kimberley,Singhal Seema,Williams Stephanie,Winter Jane,Tallman Martin,Gordon Leo,Frankfurt Olga,Evens Andrew,Mehta Jayesh

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference18 articles.

1. Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma Levels

2. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma

3. Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole

4. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia

5. Practice Guidelines for the Treatment of Coccidioidomycosis

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing;The Pharmacogenomics Journal;2023-11

2. Pharmacogenomics in allogeneic hematopoietic stem cell transplantation: Implications on supportive therapies and conditioning regimens;Best Practice & Research Clinical Haematology;2023-06

3. Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis;Journal of the European Academy of Dermatology and Venereology;2023-05-30

4. Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing;2023-05-24

5. Relevance of Pharmacogenomics to the Safe Use of Antimicrobials;Antibiotics;2023-02-21